期刊
CELLS
卷 11, 期 14, 页码 -出版社
MDPI
DOI: 10.3390/cells11142234
关键词
miRNA; lncRNA; adrenocortical tumor; ACC; adrenocortical adenoma; prognostic markers
类别
资金
- European Reference Network on Rare Endocrine Conditions (Endo-ERN)
- PRIN 2020 [2017N8CK4K]
- POR FESR 2014-2020
- RarePlatNet [CUP: B63D18000380007]
Non-coding RNAs play a crucial role in regulating gene expression and have potential applications in the diagnosis, treatment, and management of various human diseases. Dysregulation of non-coding RNAs may be involved in the development and progression of adrenocortical carcinoma.
Non-coding RNAs (ncRNAs) are a type of genetic material that do not encode proteins but regulate the gene expression at an epigenetic level, such as microRNAs (miRNAs) and long non-coding RNAs (lncRNAs). The role played by ncRNAs in many physiological and pathological processes has gained attention during the last few decades, as they might be useful in the diagnosis, treatment and management of several human disorders, including endocrine and oncological diseases. Adrenocortical carcinoma (ACC) is a rare and aggressive endocrine cancer, still characterized by high mortality and morbidity due to both endocrine and oncological complications. Despite the rarity of this disease, recently, the role of ncRNA has been quite extensively evaluated in ACC. In order to better explore the role of the ncRNA in human ACC, this review summarizes the current knowledge on ncRNA dysregulation in ACC and its potential role in the diagnosis, treatment, and management of this tumor.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据